Provention Bio, Inc.
Provention Bio, Inc. (PRVB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PRVB · as of Jun 9, 2026
Key Statistics
Explore Provention Bio, Inc. Data
prvb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
prvb competitorsPRVB
BLU
CALT
DCPH
DICE
FUSNStock Performance
Full HistoryAbout Provention Bio, Inc.
Provention Bio, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market therapies aimed at intercepting and preventing autoimmune disorders. Their lead investig…
what is provention bio, inc. · prvb stock overview · provention bio, inc. company profile · who is provention bio, inc. ceo · prvb NASDAQ · provention bio, inc. headquarters · provention bio, inc. business segments
About Stock Overview & Key Data
Provention Bio, Inc. (PRVB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 24, 2018. As of the latest trading session, PRVB stock price is $24.98, with a market capitalization of $2.4B. The stock has returned +540.51% over the past 12 months and +158.32% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Provention Bio, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Provention Bio, Inc. reported revenue of $12.9M and net income of -$113.6M. For detailed data — including Provention Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Provention Bio, Inc. (PRVB) stock price is $24.98. The stock is traded on NASDAQ under the ticker symbol PRVB. The 52-week range is $3.19 – $25.00.